» Authors » Joseph A Galanko

Joseph A Galanko

Explore the profile of Joseph A Galanko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 124
Citations 3968
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Sandler R, Hansen J, Peery A, Woosley J, Galanko J, Keku T
Clin Transl Gastroenterol . 2022 Feb; 13(3):e00467. PMID: 35166714
Introduction: Microscopic colitis, a common cause of diarrhea, is characterized by a largely normal appearance of the mucosa but increased numbers of lymphocytes in the epithelium and lamina propria on...
12.
Sandler R, Keku T, Woosley J, Sandler D, Galanko J, Peery A
World J Gastroenterol . 2022 Feb; 28(2):230-241. PMID: 35110947
Background: Microscopic colitis is a leading cause of diarrhea in the older adults. There is limited information about risk factors. We hypothesized that obesity would be associated with microscopic colitis....
13.
Cook D, Kang M, Martin T, Galanko J, Loeza G, Trembath D, et al.
Cancer Res . 2021 Nov; 82(1):90-104. PMID: 34737214
ECT2 is an activator of RHO GTPases that is essential for cytokinesis. In addition, ECT2 was identified as an oncoprotein when expressed ectopically in NIH/3T3 fibroblasts. However, oncogenic activation of...
14.
Sandler R, Keku T, Woosley J, Galanko J, Peery A
Aliment Pharmacol Ther . 2021 Sep; 54(9):1193-1201. PMID: 34514632
Background: Microscopic colitis is an increasingly common cause of watery diarrhoea. Several classes of medications have been associated with microscopic colitis in prior studies. Aims: To determine the association between...
15.
Egberg M, Galanko J, Banegas M, Roberson M, Strassle P, Phillips M, et al.
J Pediatr Gastroenterol Nutr . 2021 Jul; 73(5):620-625. PMID: 34321423
Objectives: Obese habitus can lead to adverse outcomes for colorectal surgeries due to technical challenges and pro-inflammatory immune mediators associated with excess adipose tissue. Surgical planning, pre-operative risk stratification, and...
16.
Marler J, Fujii C, Galanko J, Balbierz D, Utley D
J Med Internet Res . 2021 Jan; 23(2):e25578. PMID: 33482628
Background: Despite decreasing prevalence over the last several decades, cigarette smoking remains the leading cause of preventable death and disease, underscoring the need for innovative, effective solutions. Pivot is a...
17.
Koi M, Okita Y, Takeda K, Koeppe E, Stoffel E, Galanko J, et al.
PLoS One . 2020 Oct; 15(10):e0239676. PMID: 33027290
Black Americans (BA) have higher incidence and higher mortality rates for colorectal cancers (CRC) as compared to White Americans (WA). While there are several identified risk factors associated with the...
18.
Okita Y, Koi M, Takeda K, Ross R, Mukherjee B, Koeppe E, et al.
Gut Pathog . 2020 Oct; 12:46. PMID: 33005238
() is frequently found in colorectal cancers (CRCs). High loads of DNA are detected in CRC tissues with microsatellite instability-high (MSI-H), or with the island hypermethylation phenotype (CIMP). infection is...
19.
Marler J, Fujii C, Wong K, Galanko J, Balbierz D, Utley D
J Med Internet Res . 2020 Sep; 22(10):e22811. PMID: 32894829
Background: Tobacco use is the leading cause of preventable morbidity and mortality. Existing evidence-based treatments are underutilized and have seen little recent innovation. The success of personal biofeedback interventions in...
20.
Egberg M, Phillips M, Galanko J, Kappelman M
Inflamm Bowel Dis . 2020 May; 27(4):493-499. PMID: 32426816
Background: Hospital readmissions are a burden on patients and families and place financial strain on the health care system. Thirty-day readmission rates for adult patients undergoing colectomy are as high...